We are live on
!
Find out more
LNAI
Lunai Bioworks
LNAI
LNAI
32 hedge funds and large institutions have $6.86M invested in Lunai Bioworks in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 8
0% more ownership
Funds ownership: 0.06% → 0.06% (+0%)
3% less funds holding
Funds holding: 33 → 32 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
36% less capital invested
Capital invested by funds: $10.8M → $6.86M (-$3.92M)
Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
14
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$228K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$142K |
| 3 |
BlackRock
New York
|
+$141K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$83.3K |
| 5 |
Bank of New York Mellon
New York
|
+$51.4K |
Top Sellers
| 1 |
MWP
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
|
-$100K |
| 2 |
Morgan Stanley
New York
|
-$64.2K |
| 3 |
Renaissance Technologies
New York
|
-$58K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$39.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$39K |
